|25.Berna Biotech (Switzerland - 1898)**|
Full article >>>
Clearly, Amgen and Genentech are spending prodigious R&D sums, comparable to Big Pharma levels, but the next 3 yo 4 companies are not too far behind. This R&D is the life blood of a biotech company.
All of the above trends noted by MedAd News really only focus on the drug part of biotech. As a result, I would add the following trends:
Source:wistechnology.com By Michael Rosen 08/01/06
Related biology technology :
1. The state of global biotech: An Ernst & Young perspective
2. Olympics of biotechnology has international flavor
3. Getting noticed in Genetown: Wisconsin biotech on display
4. Madison biotech NimbleGen files for IPO; one of states best-funded firms
5. Wisconsin biotech firm receives $107K NIH grant
6. Manufacturing partnership will move into biotech and biomedical spaces
7. Wisconsin wont get Georgia biotech without a fight
8. The 10 biggest events shaping biotech in 2006
9. NimbleGen partners with UK biotech firm
10. 2006: A great biotech financing year, unless you were going public!
11. Big pharma seeks Wisconsin biotech partnerships
(Date:3/23/2017)... 2017 In today,s pre-market research, ... the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate ... SYN), and Regulus Therapeutics Inc. (NASDAQ: RGLS ... Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn ... at: ...
(Date:3/22/2017)... 22, 2017 Ascendis Pharma A/S (Nasdaq: ASND), ... technology to address significant unmet medical needs in ... full year ended December 31, 2016. ... company as we broadened our pipeline and pursued ... disease company with an initial focus on endocrinology," ...
(Date:3/22/2017)... -- iSpecimen ®, the marketplace for human ... (DPS), a full-service anatomic pathology reference lab serving ... , has joined a program offered by iSpecimen ... to make human biospecimens and associated data available to ... in 2015 as a collaboration between iSpecimen and DHIN, ...
(Date:3/22/2017)... Mass. , March 22, 2017 Boston ... next-generation cancer therapeutics designed to target cancer stemness pathways, ... Patricia S. Andrews as Chief Executive Officer, effective ... succeed Chiang J. Li , M.D., FACP, who ... ten years ago. Under his leadership, Boston Biomedical has ... Breaking Biology Technology:
(Date:3/1/2017)... 2017 Aware, Inc. (NASDAQ: AWRE), a leading supplier ... P. Moberg has resigned, effective March 3, 2017, ... Officer and Treasurer of Aware citing a desire to ... member of the Board of Directors of Aware. ... Officer and co-President, General Counsel has been named Chief ...
(Date:2/27/2017)... 2017 Strategic Cyber Ventures , the industry,s ... a $3.5 million investment in Polarity , the first ... is DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran ... this series A round of funding. This new funding ...
(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017 /PRNewswire/ ... of Companies (Avamere Health Services, Infinity Rehab, Signature Hospice, ... study that will apply the power of IBM cognitive ... and health centers. By analyzing data streaming from sensors ... into physical and environmental conditions, and obtain deeper learnings ... Breaking Biology News(10 mins):